Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks - Endpoints News

1. Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks  Endpoints News
2. Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing  Fierce Pharma
3. Nature Medicine retracts Chinese lung cancer immunotherapy timing study  동아사이언스
4. Paolo Tarantino: Nature Medicine Retracts Debated Study on Early Morning Immunotherapy Benefits  Oncodaily
5. Nature Retracts Cancer Study Suggesting Treatment Is Better Earlier in the Day  MedPage Today

from Top stories - Google News https://ift.tt/uLYp350
via Whole story